Início
Mercados
Gráficos e ideias
Algo
Notícias
Store
Corretoras
Baixar
Calendário econômico
Sinais de Negociação
Terminal web
Pressione
/
para pesquisar: @user, $symbol, ...
Pesquisar
Login
Criar uma conta
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
ORIC
#1990
Oric Pharmaceuticals, Inc. Common Stock
13.450
0
+4.59%
Setor:
Base:
Moeda do lucro:
Faixa diária
Faixa anual
Mudança diária
+4.59%
Mudança mensal
+11.80%
Mudança em 6 meses
-0.44%
Mudança anual
-0.44%
Fechamento anterior
12.860
0
Open
13.450
0
Bid
Ask
Low
13.450
0
High
13.450
0
Volume
173
Mercados
Ações
Cuidados de saúde
ORIC
Open full chart
Financials
Overview
Relatórios
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
70.57 M
71.03 M
71.09 M
97.12 M
97.39 M
100.36 M
—
Valuation ratios
Enterprise value
679.08 M
513.78 M
347.34 M
909.93 M
1.12 B
775.26 M
3.15 B
Price to earnings ratio
-5.69
-4.41
-2.97
-5.34
-6.9
-5.56
-20.77
Price to sales ratio
—
—
—
—
—
—
—
Price to cash flow ratio
6.06
4.99
3.42
6.1
7.95
6.47
23.94
Price to book ratio
0.59
2.31
0.38
0.69
0.81
1.87
3.75
Enterprise value to EBITDA ratio
—
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.11
0.13
0.12
0.1
0.08
0.07
0.38
Return on equity %
0.13
0.15
0.14
0.11
0.08
0.08
0.41
Return on invested capital %
—
-604.51
—
—
—
-42.57
—
Gross margin %
—
—
—
—
—
—
—
Operating margin %
—
—
—
—
—
—
—
EBITDA margin %
—
—
—
—
—
—
—
Net margin %
—
—
—
—
—
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
13.15
10.56
12
16.13
14.65
14.13
56.91
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
—
—
—
—
—
—
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
0.41
0.4
0.46
0.39
0.25
0.26
1.36
EBIT per share
—
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
—
Cash per share
3.86
3.67
2.87
3.62
2.9
3.21
12.59
Net current asset value per share
3.96
3.76
2.98
3.73
2.99
3.29
12.98
Tangible book value per share
3.88
3.49
3.09
4.15
4.11
4.38
15.73
Working capital per share
3.66
3.4
2.73
3.5
2.78
3.05
12.06
Book value per share
3.88
3.49
3.09
4.15
4.11
4.38
15.73
Notícias
H.C. Wainwright raises ORIC Pharmaceuticals price target on trial progress
Oppenheimer reiterates Outperform on ORIC stock, $15 target
Oric Pharmaceuticals files new $200 million at-the-market offering prospectus
Oric Pharmaceuticals director Heyman sells shares worth $80,430
ORIC: Transition To Late-Stage Development Presents Upside (NASDAQ:ORIC)
Oric Pharmaceuticals Stock Sees Healthy RS Rating Jump To 80
H.C. Wainwright reiterates Buy rating on ORIC Pharmaceuticals stock
ORIC Pharmaceuticals reports progress on cancer drug candidates
Piper Sandler initiates ORIC Pharmaceuticals stock with Overweight rating
JPMorgan’s Healthcare Focus List: Top Sector Picks in 2026
Biotech Stocks: Jefferies Names its 6 Top Picks for 2026
Wells Fargo raises ORIC Pharmaceuticals stock price target on promising cancer drug data